Drug Profile
Research programme: sodium glucose transport protein inhibitors - Lexicon Pharmaceuticals
Alternative Names: LX 4212Latest Information Update: 13 Feb 2014
Price :
$50
*
At a glance
- Originator Lexicon Pharmaceuticals
- Class Small molecules
- Mechanism of Action Sodium-glucose transporter 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Metabolic disorders; Obesity; Type 2 diabetes mellitus
Most Recent Events
- 13 Jan 2014 Discontinued - Preclinical for Metabolic disorders in USA (PO)
- 13 Jan 2014 Discontinued - Preclinical for Obesity in USA (PO)
- 13 Jan 2014 Discontinued - Preclinical for Type-2 diabetes mellitus in USA (PO)